Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.052 | 0.7 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.017 | 0.7 |